Harvard Bioscience (HBIO) Restructuring Costs (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Restructuring Costs of $200000.0 for Q1 2026, up 115.05% year-over-year from $93000.0 in Q1 2025, and up 316.67% quarter-over-quarter from $48000.0 in Q3 2025.
Harvard Bioscience (HBIO) Restructuring Costs (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Restructuring Costs for 12 consecutive years, with $200000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Restructuring Costs rose 115.05% year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $371000.0 (down 44.46% YoY), while the FY2022 annual figure was -$233000.0, down 177.67% from the prior year.
- Restructuring Costs rose to $200000.0 in Q1 2026 per HBIO's latest filing, from $48000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $5.2 million in Q1 2022 and bottomed at -$4.9 million in Q2 2022.
- Historically, Restructuring Costs has averaged $77000.0 across 4 years, with a median of $93000.0 in 2025.
- Annual changes were most pronounced in 2025 — Restructuring Costs tumbled 92.42% — and 2026, when it surged 115.05%.
- Harvard Bioscience's Restructuring Costs stood at -$544000.0 in 2022, then surged by 132.9% to $179000.0 in 2024, then tumbled by 73.18% to $48000.0 in 2025, then soared by 316.67% to $200000.0 in 2026.
- Business Quant data shows HBIO's Restructuring Costs at $200000.0 in Q1 2026, $48000.0 in Q3 2025, and $30000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 318,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Sep 30, 2025 | 48,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Sep 30, 2024 | 179,000.00 |
| Jun 30, 2024 | 396,000.00 |
| Sep 30, 2022 | -544,000.00 |
| Jun 30, 2022 | -4.90 Mn |
| Mar 31, 2022 | 5.19 Mn |
| Dec 31, 2021 | 300,000.00 |
| Dec 31, 2016 | 1,000.00 |
| Sep 30, 2016 | -17,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Mar 31, 2016 | 11,000.00 |
| Dec 31, 2015 | 301,000.00 |
| Sep 30, 2015 | 376,000.00 |
| Jun 30, 2015 | 54,000.00 |
| Mar 31, 2015 | 57,000.00 |
| Dec 31, 2014 | 678,000.00 |